Wave Financial Statements From 2010 to 2025

Stocks . USA . 
Stock . Wave Life Sciences
WVE Stock  USD 10.17  0.05  0.49%   
Wave Life financial statements provide useful quarterly and yearly information to potential Wave Life Sciences investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Wave Life financial statements helps investors assess Wave Life's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Wave Life's valuation are summarized below:
Gross Profit
-51.4 M
Profit Margin
(0.90)
Market Capitalization
1.6 B
Enterprise Value Revenue
11.9292
Revenue
108.3 M
There are over one hundred nineteen available fundamental gauges for Wave Life Sciences, which can be analyzed over time and compared to other ratios. Investors should ensure to confirm all of Wave Life's prevalent performance against the performance from 2010 to 2025 to make sure the company is sustainable down the road. The current year's Market Cap is expected to grow to about 1.8 B. The current year's Enterprise Value is expected to grow to about 1.5 B

Wave Life Total Revenue

113.72 Million

Check Wave Life financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Wave Life's main balance sheet or income statement drivers, such as Depreciation And Amortization of 11.1 M, Interest Expense of 1.8 M or Selling General Administrative of 36.3 M, as well as many indicators such as Price To Sales Ratio of 15.0, Dividend Yield of 0.0 or PTB Ratio of 15.68. Wave financial statements analysis is a perfect complement when working with Wave Life Valuation or Volatility modules.
  
Check out the analysis of Wave Life Correlation against competitors.

Wave Life Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets216.1 M352.2 M161.3 M
Slightly volatile
Short and Long Term Debt Total21.1 M25.4 M16.3 M
Slightly volatile
Other Current Liabilities22.1 M21.1 M8.5 M
Slightly volatile
Total Current Liabilities77.8 M111 M59.8 M
Slightly volatile
Other Liabilities96.6 M92 M40.3 M
Slightly volatile
Property Plant And Equipment Net30.2 M28 M22.8 M
Slightly volatile
Current Deferred Revenue52.5 M66 M39.2 M
Slightly volatile
Accounts Payable9.6 M16.3 M7.2 M
Slightly volatile
Cash156.2 M302.1 M116.3 M
Slightly volatile
Non Current Assets Total41.8 M31.8 M31.4 M
Slightly volatile
Other Assets4.1 M4.3 M8.2 M
Pretty Stable
Cash And Short Term Investments156.2 M302.1 M116.3 M
Slightly volatile
Common Stock Total Equity969.4 M923.3 M411.3 M
Slightly volatile
Common Stock Shares Outstanding145.2 M138.3 M49.2 M
Slightly volatile
Liabilities And Stockholders Equity216.1 M352.2 M161.3 M
Slightly volatile
Non Current Liabilities Total16.9 M17.8 M39 M
Slightly volatile
Other Current Assets9.5 M16.9 M7.1 M
Slightly volatile
Total Liabilities134.8 M142.7 M102.2 M
Slightly volatile
Property Plant And Equipment Gross38.4 M74.3 M28.8 M
Slightly volatile
Preferred Stock Total Equity7.4 M9.1 M6.5 M
Slightly volatile
Total Current Assets174.2 M320.4 M129.8 M
Slightly volatile
Short Term Debt6.3 M7.6 M6.5 M
Pretty Stable
Common Stock1.2 B1.2 B451.8 M
Slightly volatile
Property Plant Equipment22.5 M19.9 M16.8 M
Slightly volatile
Other Stockholder Equity164.3 M156.5 M51.8 M
Slightly volatile
Short and Long Term Debt13.7 K14.4 K41.8 K
Slightly volatile
Warrants6.3 M7.1 M7.7 M
Slightly volatile
Non Currrent Assets Other6.5 M3.8 M5.8 M
Pretty Stable
Long Term Debt Total13.7 K14.4 K39 K
Slightly volatile
Capital Surpluse144.2 M137.4 M51.6 M
Slightly volatile
Capital Lease Obligations22.1 M25.4 M14 M
Slightly volatile
Non Current Liabilities Other135.3 M128.9 M41.7 M
Slightly volatile
Deferred Long Term Asset Charges413.6 K644 K418.1 K
Slightly volatile
Net Working Capital104.9 M209.4 M111.5 M
Slightly volatile
Long Term Investments40 M45 M49.1 M
Slightly volatile
Capital Stock828.5 M1.2 B568.9 M
Slightly volatile

Wave Life Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Selling General Administrative36.3 M59 M27.3 M
Slightly volatile
Other Operating Expenses137.3 M218.7 M102.8 M
Slightly volatile
Research Development101 M159.7 M75.5 M
Slightly volatile
Total Operating Expenses137.3 M218.7 M102.8 M
Slightly volatile
Total Other Income Expense Net14.1 M13.4 M4.7 M
Slightly volatile
Cost Of Revenue10.1 M10.6 M43.5 M
Pretty Stable
Interest Income2.2 M1.8 M1.3 M
Slightly volatile
Non Operating Income Net Other1.7 M1.8 M2 M
Slightly volatile
Reconciled Depreciation8.9 M8.7 M5.5 M
Slightly volatile
Selling And Marketing Expenses7.4 M8.3 M9 M
Slightly volatile

Wave Life Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Begin Period Cash Flow130.8 M204.1 M97.5 M
Slightly volatile
Depreciation6.1 M8.7 M4.6 M
Slightly volatile
Capital Expenditures891.1 K938 K2.9 M
Very volatile
Total Cash From Financing Activities266.6 M253.9 M92.5 M
Slightly volatile
End Period Cash Flow158.5 M305.8 M118.1 M
Slightly volatile
Sale Purchase Of Stock91.9 M76 M63 M
Slightly volatile
Stock Based Compensation12.9 M13.1 M8.9 M
Slightly volatile
Change To Netincome13.5 M19.8 M10.1 M
Slightly volatile
Issuance Of Capital Stock133.6 M236.2 M91.5 M
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio15.015.7937473
Slightly volatile
Days Sales Outstanding4.554.7924141
Very volatile
Stock Based Compensation To Revenue0.09440.099410.9462
Slightly volatile
Capex To Depreciation0.130.141.5435
Pretty Stable
EV To Sales12.5813.239164.0865
Pretty Stable
Inventory Turnover16.313.6915.0263
Pretty Stable
Days Of Inventory On Hand20.327.624.8739
Pretty Stable
Payables Turnover0.780.8212.2429
Slightly volatile
Sales General And Administrative To Revenue0.520.54528.2941
Slightly volatile
Research And Ddevelopement To Revenue1.41.474429.499
Slightly volatile
Capex To Revenue0.01080.01135.2231
Slightly volatile
Cash Per Share2.082.18463.2947
Very volatile
Days Payables Outstanding601585452
Very volatile
Income Quality0.770.390.7558
Slightly volatile
Current Ratio2.742.88775.0166
Very volatile
Receivables Turnover79.9776.161712.7996
Slightly volatile
Capex Per Share0.01150.01210.1078
Very volatile
Revenue Per Share0.820.78320.3301
Slightly volatile
Interest Debt Per Share0.280.18370.3684
Very volatile
Debt To Assets0.06850.07211.0918
Slightly volatile
Operating Cycle4.554.7924121
Pretty Stable
Days Of Payables Outstanding601585452
Very volatile
Ebt Per Ebit1.060.87870.9742
Slightly volatile
Long Term Debt To Capitalization0.05650.07040.0502
Slightly volatile
Quick Ratio2.742.88774.9943
Very volatile
Net Income Per E B T0.790.890.9542
Very volatile
Cash Ratio2.592.72264.8313
Very volatile
Days Of Inventory Outstanding20.327.624.8739
Pretty Stable
Days Of Sales Outstanding4.554.7924141
Very volatile
Free Cash Flow Operating Cash Flow Ratio1.221.05741.1073
Pretty Stable
Fixed Asset Turnover4.063.86820.8701
Slightly volatile
Debt Ratio0.06850.07211.0918
Slightly volatile
Price Sales Ratio15.015.7937473
Slightly volatile
Asset Turnover0.320.30750.0921
Slightly volatile

Wave Life Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap1.8 B1.7 B566.9 M
Slightly volatile
Enterprise Value1.5 B1.4 B397.3 M
Slightly volatile

Wave Fundamental Market Drivers

Cash And Short Term Investments302.1 M

Wave Upcoming Events

27th of March 2024
Upcoming Quarterly Report
View
1st of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
27th of March 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Wave Life Financial Statements

Wave Life stakeholders use historical fundamental indicators, such as Wave Life's revenue or net income, to determine how well the company is positioned to perform in the future. Although Wave Life investors may analyze each financial statement separately, they are all interrelated. For example, changes in Wave Life's assets and liabilities are reflected in the revenues and expenses on Wave Life's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Wave Life Sciences. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue66 M52.5 M
Total Revenue108.3 M113.7 M
Cost Of Revenue10.6 M10.1 M
Stock Based Compensation To Revenue 0.10  0.09 
Sales General And Administrative To Revenue 0.54  0.52 
Research And Ddevelopement To Revenue 1.47  1.40 
Capex To Revenue 0.01  0.01 
Revenue Per Share 0.78  0.82 
Ebit Per Revenue(1.02)(1.07)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
VVisa Class A
CRMSalesforce
CRMSalesforce
When determining whether Wave Life Sciences is a strong investment it is important to analyze Wave Life's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Wave Life's future performance. For an informed investment choice regarding Wave Stock, refer to the following important reports:
How To Invest In Wave
Details
Is Wave Stock a good investment?
Details
What is Wave Life's Net Worth?
Details
Largest Pharmaceuticals Companies
View
Largest Pharmaceuticals, Biotechnology & Life Sciences Companies
View
Check out the analysis of Wave Life Correlation against competitors.
You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Wave Life. If investors know Wave will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Wave Life listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.70)
Revenue Per Share
0.783
Quarterly Revenue Growth
1.882
Return On Assets
(0.22)
Return On Equity
(0.73)
The market value of Wave Life Sciences is measured differently than its book value, which is the value of Wave that is recorded on the company's balance sheet. Investors also form their own opinion of Wave Life's value that differs from its market value or its book value, called intrinsic value, which is Wave Life's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Wave Life's market value can be influenced by many factors that don't directly affect Wave Life's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Altman
Z Score
Details
Piotroski
F Score
Details
Beneish
M Score
Details
Financial
Analysis
Details
Buy or Sell
Advice
Details
Earnings
Projections
Details
Please note, there is a significant difference between Wave Life's value and its price as these two are different measures arrived at by different means. Investors typically determine if Wave Life is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Wave Life's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY